Table 1.
COVID-19 Patients (n = 72) | Non-COVID-19 Sepsis (n = 11) | |
---|---|---|
Age, yr | 60 ± 14 | 57 ± 14 |
Male, n (%) | 42 (58) | 3 (27) |
Race, n (%) | ||
Black | 51 (71) | 4 (36) |
White | 17 (24) | 6 (55) |
Asian | 4 (5) | 1 (9) |
Ventilator/oxygen support, n (%) | ||
Invasive ventilation | 25 (35) | 5 (45) |
Noninvasive ventilation* | 13 (18) | 2 (18) |
Nasal cannula oxygen | 22 (31) | 3 (27) |
No support | 12 (17) | 1 (9) |
ARDS, n (%)† | 24 (33) | 2 (18) |
Septic shock, n (%) | 16 (22) | 6 (55) |
Clotting complication, n (%) | 15 (21) | 4 (36) |
Mortality, n (%) | 13 (18) | 2 (18) |
*Noninvasive ventilation includes noninvasive mask ventilation, helmet ventilation, and high flow nasal cannula oxygenation. †Acute respiratory distress syndrome (ARDS) defined by the Berlin criteria with the added requirement of invasive mechanical ventilation.